Skip to main navigation Skip to search Skip to main content

Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative

  • Tine Cuppens
  • , Daniela Annibali
  • , An Coosemans
  • , Jone Trovik
  • , Natalja ter Haar
  • , Eva Colas
  • , Angel Garcia-Jimenez
  • , Koen Van de Vijver
  • , Roy P. M. Kruitwagen
  • , Mariel Brinkhuis
  • , Michal Zikan
  • , Pavel Dundr
  • , Jutta Huvila
  • , Olli Carpen
  • , Johannes Haybaeck
  • , Farid Moinfar
  • , Helga B. Salvesen
  • , Maciej Stukan
  • , Carole Mestdagh
  • , Ronald P. Zweemer
    • Leonardus F. Massuger, Michael R. Mallmann, Eva Wardelmann, Miriam Mints, Godelieve Verbist, Debby Thomas, Ellen Gomme, Els Hermans, Philippe Moerman, Tjalling Bosse, Frederic Amant*
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

51 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science